Don't Just Read the News, Understand It.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Artificial Intelligence
Social Media
Donald Trump
Taxes
Cryptocurrency
European Union
Eid
Property
India Economy
Bitcoin
Natural Disasters
Crime
Published • loading... • Updated

ESPID 2025: Maternal RSV Vaccine Cuts Infant Admissions in Argentina

Summary by European Medical Journal
These real-world results support the effectiveness of maternal RSV vaccination and could influence policy decisions in other countries.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
European Medical JournalEuropean Medical Journal

ESPID 2025: Maternal RSV Vaccine Cuts Infant Admissions in Argentina

These real-world results support the effectiveness of maternal RSV vaccination and could influence policy decisions in other countries.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

European Medical Journal broke the news in on Saturday, May 31, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Vaccinations

Vaccinations

Argentina

Argentina

News
For You
SearchBlindspotLocal